Skip to main content

Machado Patrick

No open-market purchases or sales filed in the past year.

Current role at each company

  • ALMSAlumis Inc.Directoras of Jul 2, 2026
  • RCUSArcus Biosciences, Inc.Directoras of Jun 12, 2026
  • XENEXenon Pharmaceuticals Inc.Directoras of Jun 3, 2026
  • ADVMAdverum Biotechnologies, Inc.Directoras of Dec 10, 2025
  • SLRNACELYRIN, Inc.Directoras of May 23, 2025
Show 2 more companies
  • CMRXChimerix IncDirectoras of Jun 12, 2023
  • TPTXTurning Point Therapeutics, Inc.Directoras of Aug 17, 2022

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Machado Patrick as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

No insider trades match these filters.